Emine Cifcibasi

Emine Cifcibasi


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MBMeltem Bayrak
Meltem Bayrak
NONecla Asli Kocak Oztug
Necla Asli Kocak Oztug
Karan GulatiKaran Gulati
Karan Gulati
SCSerdar Cintan
Serdar Cintan
ECEmine Cifcibasi
Emine Cifcibasi
The study aims: 1. To perform diode laser, titanium (Ti) brush, and Ti curette treatment on sandblasted and acid-etched (SLA) Ti surfaces, with/without H2O2 and CHX, 2. To investigate the influence of decontamination techniques on implant surface topography and hydrophilicity. Diode laser, Ti brush, and Ti curette treatments were performed on the Grade 4 Ti discs, with/without treatment with 3% H2O2 solution or 0.2% CHX. Surface characteristics were investigated via SEM, optical profilometry, and water contact angle meter. SEM findings revealed flat and scratched areas when treated with Ti curette and Ti brush. For diode laser, SEM showed melting in specific areas. Ra and Rt values were lower in all test groups than in the control group (p < 0.05). The adjunctive chemical treatment showed negligible effects in SEM images and surface roughness measurements compared to laser and mechanical treatment-only groups. H2O2 treatment resulted in enhanced hydrophilicity in either treatment modalities with a significant difference compared to the negative control group (p < 0.05). In all test groups, the hydrophilicity was enhanced compared to the negative control group (p < 0.05). Diode laser treatment had the least disruptive effect on the Ti surface characteristics. The use of other mechanical methods caused significant alterations in the surface roughness.

31 July 2024 in Clinical Oral Investigations
Verified
Journal Article
Open access
PDF file
ECElif İlke Cebesoy
Elif İlke Cebesoy
MAMüge Altaca
Müge Altaca
NONecla Asli Kocak Oztug
Necla Asli Kocak Oztug
IBIlknur Bingül
Ilknur Bingül
ECEmine Cifcibasi
Emine Cifcibasi
Objective: We assessed the levels of Interleukin-10 (IL-10), Interleukin-12 (IL-12), and Interleukin-18 (IL-18) in the gingival crevicular fluid (GCF) of subjects with advanced periodontitis (SIII-SIV) compared to healthy controls and evaluated their correlations with clinical measurements. Methods: This cross-sectional study involved subjects (n = 60) diagnosed with stage III grade B-C (n = 13) to stage IV grade C (n = 17) periodontitis, and periodontally healthy controls (n = 30). Clinical periodontal measurements involved full-mouth. The concentrations of IL-10, IL-12, and IL-18 were determined using enzyme-linked immunosorbent assay (ELISA). Results: There were no significant differences in IL-12 level and IL-18/IL-10 ratio between the healthy and periodontitis groups (p = 0.413, p = 0.636, respectively). The IL-10 and IL-18 levels were significantly higher in the periodontitis group than in controls (p < 0.001, p < 0.001, respectively). Significant associations were observed between the periodontitis and IL-10 and IL-18 levels (OR = 1.46, %95 CI 1.19–1.795; OR = 1.13, %95 CI 1.059–1.207, respectively) (p < 0.001, p < 0.001, respectively). Conclusions: There was a correlation between pocket depth and the presence of IL-18 and a strong association between periodontitis and a high level of IL-18. However, there were no direct correlations among the three biomarkers and IL-18/IL-10 ratio, indicating that their roles in periodontal health are complex and multidimensional. Clinical relevance: Understanding the cytokine dynamics in GCF provides valuable insights into their potential clinical implications for periodontal disease diagnosis, risk assessment, and tailored therapeutic interventions.

30 August 2024 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
MAMüge Altaca
Müge Altaca
ECElif İlke Cebesoy
Elif İlke Cebesoy
NONecla Asli Kocak Oztug
Necla Asli Kocak Oztug
IBIlknur Bingül
Ilknur Bingül
ECEmine Cifcibasi
Emine Cifcibasi
Background: This study compared the concentrations of interleukin (IL)-6, IL-17, and IL-35 in the gingival crevicular fluid of periodontally healthy participants with individuals who had stage III and IV periodontitis. Methods: In total, 60 participants with stage III grade B-C (n = 12)—stage IV grade C (n = 18) periodontitis and 30 healthy controls were included in this cross-sectional study. Full-mouth clinical periodontal measurements were performed. Concentrations of IL-6, IL-17, and IL-35 were determined using enzyme-linked immunosorbent assays. Parametric/nonparametric methods, Pearson’s/Spearman’s correlation, and logistic regression methods were used for data analyses. Results: The periodontitis group exhibited significantly higher levels of IL-6, IL-17, and IL-35 compared with the healthy group (p < 0.001). IL-17 levels had a positive correlation with pocket depth (PD) (r = 0.395; p = 0.031) in the periodontitis group. IL-6, IL-17, and IL-35 levels were associated with periodontitis (odds ratio [OR] = 1.344, 95% confidence interval [CI] = 1.159–1.56; OR = 1.063, 95% CI = 1.025–1.102; OR = 1.261, 95% CI = 1.110–1.434, respectively) (p < 0.001, p = 0.001, p < 0.001, respectively). Full-mouth and sampling sites PD and clinical attachment loss (CAL) values were significantly higher in the periodontitis group than in the healthy group (p < 0.001). Conclusions: This study revealed upregulated levels of IL-6, IL-17, and IL-35 in periodontitis patients compared to healthy individuals. IL-17 shows a correlation with increased PD. These findings suggest a potential association between these cytokines and severe and advanced periodontitis. Trial registration: The trial was registered in ClinicalTrials.gov with this identifier NCT05306860 on 24/01/2022.

14 September 2026 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
ECElif İlke Cebesoy
Elif İlke Cebesoy
MUMurat Uslu
Murat Uslu
GGGuven Gunver
Guven Gunver
FPFerda Pamuk
Ferda Pamuk
ECEmine Cifcibasi
Emine Cifcibasi
Free gingival graft (FGG) harvesting is frequently associated with postoperative morbidity, driving the search for effective adjunctive agents. This retros

20 October 2026 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
EGEmrah Genceli
Emrah Genceli
HAHilal Ağar
Hilal Ağar
SDSüleyman Çağatay Dayan
Süleyman Çağatay Dayan
SÇSerdar Çintan
Serdar Çintan
ECEmine Cifcibasi
Emine Cifcibasi
Background: Primary implant stability is a key determinant of successful osseointegration, particularly in the posterior maxilla, where bone quality is often compromised. Short implants have been proposed as an alternative to sinus floor elevation; however, data comparing their primary stability with that of standard implants placed using closed sinus floor elevation remain limited. This in vitro study aimed to compare the primary stability of short and standard implants. Materials and methods: An in vitro experimental model was used to assess primary implant stability. Short implants and standard implants placed following simulated closed sinus floor elevation were evaluated using resonance frequency analysis and Periotest measurements ( n = 40). Implant stability values were obtained from frontal and lateral directions, with five readings averaged in each direction for every implant. Descriptive statistics were calculated, and group comparisons were performed. Pearson correlation analysis was used to evaluate relationships between measurement directions within each implant group and between assessment methods. Results: No statistically significant differences in primary stability were observed between short implants and standard implants based on either resonance frequency analysis or Periotest measurements ( p > 0.05). Conclusions: Within the limitations of this in vitro model, no statistically significant difference in primary stability was detected between short and standard implants under similar crestal bone engagement. As healing, secondary stability, and loading were not assessed, clinical studies are required to confirm these findings. Trial registration: Not applicable.